Lenz Robert A.
Insider CIK 1992908 · LBRX Director · NBP Director · NMRA Head of R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBP NovaBridge Biosciences | M Exercise deriv | 2026-08-22 | 2026-08-25 | 7,486 | — | $0 | 14,974 | SEC↗ |
| NBP NovaBridge Biosciences | M Exercise | 2026-08-22 | 2026-08-25 | 17,218 | — | $0 | 17,218 | SEC↗ |
| NBP NovaBridge Biosciences | M Exercise deriv | 2026-08-22 | 2026-08-25 | 7,486 | — | $0 | 14,974 | SEC↗ |
| NBP NovaBridge Biosciences | M Exercise | 2026-08-22 | 2026-08-25 | 17,218 | — | — | 17,218 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2026-06-03 | 2026-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2026-03-06 | 2026-03-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2025-02-18 | 2025-02-20 | 5,614 | $1.67 | $9.4K | 309,092 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 502,934 | — | $0 | 502,934 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 100,000 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 502,934 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2024-10-10 | 2024-10-11 | 8,260 | $15.09 | $124.6K | 314,706 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2024-10-09 | 2024-10-11 | 5,563 | $15.01 | $83.5K | 322,966 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2024-09-18 | 2024-09-19 | 10,676 | $12.09 | $129.1K | 328,529 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2024-09-17 | 2024-09-19 | 30,788 | $11.81 | $363.6K | 339,205 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2024-09-12 | 2024-09-16 | 32,948 | $11.43 | $376.6K | 369,993 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award | 2024-02-14 | 2024-02-16 | 50,000 | — | $0 | 402,941 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2023-09-14 | 2023-09-18 | 502,934 | — | $0 | 502,934 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award | 2023-09-14 | 2023-09-18 | 352,941 | — | $0 | 352,941 | SEC↗ |